Actively Recruiting
Use of Pulsed Low-dose Rate Re-irradiation for Recurrent Glioma (PULSAR)
Led by Centro di Riferimento Oncologico - Aviano · Updated on 2023-09-26
29
Participants Needed
1
Research Sites
261 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Re-irradiation in gliomas is a therapeutic option at recurrence before of 2nd-line chemotherapy. The dose of re-irradiation with conventional fractionation is unfortunately limited by the risk of symptomatic radionecrosis that is significant for cumulative doses above 100 Gy. The use of unconventional low dose rate pulsed radiotherapy (pLDRT) can reduce the risk of radiotoxicity while taking advantage of the cellular hyper-radiosensitivity that occurs at low dose-rates. The present study therefore aims at evaluating whether the use of pLDRT in the re-irradiation of recurrences of gliomas allows maintaining a low risk of symptomatic radionecrosis even for cumulative doses greater than 100 Gy.
CONDITIONS
Official Title
Use of Pulsed Low-dose Rate Re-irradiation for Recurrent Glioma (PULSAR)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 6518 years
- Ability to provide informed consent for treatment
- Diagnosis of cerebral glioma
- Confirmation of disease recurrence or relapse by histology or imaging
- Previous brain radiation therapy completed at least 6 months prior
- Performance status of ECOG 0 to 2
You will not qualify if you...
- Refusal to undergo radiation treatment or absence of informed consent
- Receiving chemotherapy at the same time
- Presence of leptomeningeal spread or tumor in both cerebral hemispheres
- Current pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS-Centro di Riferimento Oncologico (CRO) di Aviano
Aviano, Pordenone, Italy, 33081
Actively Recruiting
Research Team
L
Lorenzo Vinante, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here